Clinical Trials Logo

Filter by:
NCT ID: NCT03980249 Withdrawn - Glioblastoma Clinical Trials

Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells

Start date: September 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this pilot study is to evaluate the addition of carvedilol with standard of care treatment to determine if it will improve progression-free survival in the front line setting in patients with glioblastoma multiforme (GBM). In addition, monitoring of circulating tumor cells (CTCs) by a real-time reverse transcriptase polymerase chain reaction (qRT-PCR) assay to correlate with the clinical findings.

NCT ID: NCT03979664 Withdrawn - Psoriasis Clinical Trials

Iontophoresis in Psoriasis

Start date: March 2021
Phase: Early Phase 1
Study type: Interventional

Iontophoresis potentially may be a good alternative to improved delivery of corticosteroids. Study Investigators propose to use iontophoresis to increase dexamethasone delivery into thick psoriasis plaques. The primary purpose of this study is to assess whether dexamethasone sodium phosphate iontophoresis is an effective local therapy for psoriasis. The objective of the study is to determine the efficacy of dexamethasone sodium phosphate iontophoresis for psoriasis.

NCT ID: NCT03975192 Withdrawn - Clinical trials for Opiate Withdrawal Syndrome

Neurostimulation for Opiate Withdrawal in the PICU

NOW
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This is a prospective pilot study to investigate the effects of Percutaneous Electrical Nerve Field Stimulation (PENFS) on symptoms of opioid withdrawal in pediatric patients in the intensive care unit.

NCT ID: NCT03973346 Withdrawn - Clinical trials for Health Social Determinant

Impact of Social Risk Decision Support

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the impact of embedding a risk-stratification tool, designed to identify patient needs for services that address social determinant of health related needs, in a commercial electronic health record system (EHR).

NCT ID: NCT03972683 Withdrawn - Vasodilation Clinical Trials

Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training

Start date: April 16, 2019
Phase: Early Phase 1
Study type: Interventional

The overall goal of this study is to address fundamental questions regarding how the molecule acetylcholine interacts with the sympathetic nervous system to regulate blood flow and oxygen delivery to working skeletal muscle in young and older adults. With advancing age, blood vessels supplying active muscle lose their ability to override sympathetic constriction, which limits delivery of oxygen and results in fatigue. Findings from these studies will serve as the foundation for new strategies to improve regional blood flow regulation in older adults and clinical populations, which will increase quality of life and help to preserve functional independence.

NCT ID: NCT03972111 Withdrawn - Smallpox Clinical Trials

A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

Start date: January 1, 2020
Phase:
Study type: Observational

Phase 4, Observational Field Study in Patients Treated With TPOXX for Smallpox Disease

NCT ID: NCT03972046 Withdrawn - Melanoma (Skin) Clinical Trials

Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma

Start date: June 24, 2019
Phase: Phase 2
Study type: Interventional

This study will investigate whether the use of talimogene laherparepvec (T-VEC) in combination with BRAF/MEK inhibitor will result in durable regional and distant recurrence free survival in the neoadjuvant setting for treatment of advanced nodal BRAF mutant melanoma.

NCT ID: NCT03971149 Withdrawn - Heart Failure Clinical Trials

EMPOWER Study, a Personalized Home Care Intervention for Older Heart Failure Patients

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to see how investigators may best improve treatment adherence and disease management for heart failure after hospital discharge. This is because the period after hospital discharge is critical to long-term recovery, overall quality of life, and prevention of future hospitalizations. In this study, a trained nurse interventionist will work with the participants to develop a personalized adherence enhancement strategy for heart failure diagnosis. The personalized adherence enhancement strategy is called EMPOWER.

NCT ID: NCT03968835 Withdrawn - Clinical trials for Amputation, Traumatic

A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

Start date: December 24, 2018
Phase:
Study type: Observational

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

NCT ID: NCT03968640 Withdrawn - Clinical trials for Multiple Organ Failure

Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients

Start date: July 1, 2018
Phase: Phase 3
Study type: Interventional

This multi-center prospective intervention study is designed to develop coenzyme Q10 (CoQ10) supplementation as a cost-effective adjunctive therapy for burn injury. The long-term goals of this project are to establish the beneficial effects of CoQ10 on multiple organ dysfunction and on the clinical and functional outcomes of burn victims.